MA40303A1 - Macrocyclic peptides useful as immunomodulators - Google Patents
Macrocyclic peptides useful as immunomodulatorsInfo
- Publication number
- MA40303A1 MA40303A1 MA40303A MA40303A MA40303A1 MA 40303 A1 MA40303 A1 MA 40303A1 MA 40303 A MA40303 A MA 40303A MA 40303 A MA40303 A MA 40303A MA 40303 A1 MA40303 A1 MA 40303A1
- Authority
- MA
- Morocco
- Prior art keywords
- immunomodulators
- peptides useful
- macrocyclic peptides
- useful
- macrocyclic
- Prior art date
Links
- 239000002955 immunomodulating agent Substances 0.000 title abstract 2
- 229940121354 immunomodulator Drugs 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés qui sont des immunomodulateurs et qui sont donc utiles pour l'amélioration de diverses maladies, notamment le cancer et des maladies infectieuses.The present invention relates to compounds that are immunomodulators and are therefore useful for ameliorating various diseases, including cancer and infectious diseases.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462079944P | 2014-11-14 | 2014-11-14 | |
| PCT/US2015/060265 WO2016077518A1 (en) | 2014-11-14 | 2015-11-12 | Macrocyclic peptides useful as immunomodulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA40303A1 true MA40303A1 (en) | 2018-08-31 |
| MA40303B1 MA40303B1 (en) | 2020-01-31 |
Family
ID=58688528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA40303A MA40303B1 (en) | 2014-11-14 | 2015-11-12 | Macrocyclic peptides useful as immunomoldulators |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR102651A1 (en) |
| MA (1) | MA40303B1 (en) |
-
2015
- 2015-11-12 MA MA40303A patent/MA40303B1/en unknown
- 2015-11-13 AR ARP150103712A patent/AR102651A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AR102651A1 (en) | 2017-03-15 |
| MA40303B1 (en) | 2020-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39285A (en) | MACROCYCLIC PEPTIDES USEFUL AS IMMUNOMOLDULATORS | |
| SA519402400B1 (en) | Compositions and methods for the treatment of hemoglobinopathies | |
| GEP20247593B (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
| MX2020009649A (en) | Monoclonal antibodies against bcma. | |
| PH12018501378A1 (en) | Compositions and methods for the treatment of hemoglobinopathies | |
| MX2018009325A (en) | Compounds and methods of treating rna-mediated diseases. | |
| EA201891200A1 (en) | COMPOSITIONS CONTAINING BACTERIAL STRAINS | |
| PH12017500296A1 (en) | Anti-tigit antibodies | |
| MX2018016038A (en) | Compounds and methods for modulating rna function. | |
| EA201891202A1 (en) | COMPOSITIONS CONTAINING BACTERIAL STRAINS | |
| EA201891201A1 (en) | COMPOSITIONS CONTAINING BACTERIAL STRAINS | |
| PH12016501107A1 (en) | Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology | |
| EA201890050A1 (en) | COMPOSITIONS CONTAINING BACTERIAL STRAINS | |
| EA201890049A1 (en) | COMPOSITIONS CONTAINING BACTERIAL STRAINS | |
| MX2018010295A (en) | Antibodies having specificity for btla and uses thereof. | |
| MX2017016169A (en) | Anti-her2 antibodies and methods of use. | |
| EA201692526A1 (en) | SUBSTITUTED [1,2,4] TRIAZOLE COMPOUNDS | |
| PH12019501872A1 (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
| MX388026B (en) | Compounds and methods for modulating bruton's tyrosine kinase | |
| SG11201811429XA (en) | Flow reactor | |
| MX2017003953A (en) | High-coverage, low odor malodor counteractant compounds and methods of use. | |
| MX2020003219A (en) | Antibodies having specificity for btn2 and uses thereof. | |
| MX382092B (en) | Heterocyclic compounds for the treatment of disease | |
| MX2020000636A (en) | Synthetic proteins and therapeutic uses thereof. | |
| MX370897B (en) | Fused bicyclic compounds for the treatment of disease |